What is the current Price Target for the Alterity Therapeutics Ltd. Sponsored ADR stock?

The average Alterity Therapeutics Ltd. Sponsored ADR target price is $0.67. This is -80.76% lower than the current stock price. The highest price target is -80.19%, the lowest is -80.95%. 3 Analysts have issued a price target Alterity Therapeutics Ltd. Sponsored ADR 2027 .

How high will the Alterity Therapeutics Ltd. Sponsored ADR stock rise?

No reliable answer can be given as to how high the Alterity Therapeutics Ltd. Sponsored ADR stock will rise. The performance of stocks, including the Alterity Therapeutics Ltd. Sponsored ADR stock, depends on a variety of factors, such as the general economic situation, the company's business results, investor expectations and global events.

What's going on with the Alterity Therapeutics Ltd. Sponsored ADR stock today?

The performance of Alterity Therapeutics Ltd. Sponsored ADR stock on any given day can be influenced by various factors, such as market conditions, industry trends, company news and global events.

Why did the Alterity Therapeutics Ltd. Sponsored ADR stock fall?

The decline in Alterity Therapeutics Ltd. Sponsored ADR stock may be due to a variety of factors, such as market conditions, industry trends, company news, macroeconomic events or changes in investor expectations. It is important to note that stock markets are inherently volatile and the performance of an individual stock on any given day is not necessarily indicative of its long-term performance.

What is a price target?

A price target is an estimate by an analyst or investment bank of where a company's stock price could be in a certain period of time, usually 12 months.

Alterity Therapeutics Ltd. Sponsored ADR Forecast, price target & analysts

$3.49

4.38%

Nasdaq, Oct 01, 04:00 pm EDT. Closed.

ISIN

US02155X1063

Symbol

ATHE

Reports

Quarter | Annual

Index

NASDAQ Composite

Sector

Pharmaceuticals, Biotechnology & Life Sciences

Industry

Biotechnology

Overview Analysts Charts Ownership News Strategies

Alterity Therapeutics Ltd. Sponsored ADR Target price 2026 - Analyst rating & recommendation

Alterity Therapeutics Ltd. Sponsored ADR Classifications & Recommendation

Buy

80%

Hold

20%

Alterity Therapeutics Ltd. Sponsored ADR Price Target

Target Price	$0.67
Price	$3.49
Deviation	80.76% register free of charge
Number of Estimates	3

	3 Analysts have issued a price target Alterity Therapeutics Ltd. Sponsored ADR 2027 . The average Alterity Therapeutics Ltd. Sponsored ADR target price is $0.67. This is 80.76% register free of charge lower than the current stock price. The highest price target is $0.69 80.19% register free of charge , the lowest is $0.66 80.95% register free of charge .
	A rating was issued by 5 analysts: 4 Analysts recommend Alterity Therapeutics Ltd. Sponsored ADR to buy, 1 to hold and 0 to sell.
	Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
	Analyst Estimates: Analysts believe that the Alterity Therapeutics Ltd. Sponsored ADR stock has an average upside potential 2027 of 80.76% register free of charge . Most analysts recommend the Alterity Therapeutics Ltd. Sponsored ADR stock at Purchase.

Earnings per share, P/E ratio and EV/sales Estimates 2027, 2028 to 2033

Create a premium account to unlock analyst estimates. Learn more

Annually

	Jun '26	2027 Estimates
Earnings Per Share $	-0.08	-3.50
	14.29%	4,275.00%
P/E		negative

2 Analysts have issued a Alterity Therapeutics Ltd. Sponsored ADR forecast for earnings per share. The average Alterity Therapeutics Ltd. Sponsored ADR EPS is

unlock

. This is

unlock

than earnings per share in the financial year 2026. The highest EPS forecast is

unlock

, the lowest is

unlock

This results in the following potential growth metrics and future valuations:

2026	$-0.08	14.29%
2027	$-3.50 4,275.00% unlock
2028	$-3.50 0.00% unlock
2029	$0.00 100.00% unlock

Current
2027	-1.00 97.71% unlock
2028	-1.00 0.00% unlock

Alterity Therapeutics Ltd. Sponsored ADR...

Current Alterity Therapeutics Ltd. Sponsored ADR Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more

Analyst	Rating	Action	Date
CANACCORD GENUITY	Locked ➜ Locked	Locked	Aug 12 2026
CANACCORD GENUITY	Locked ➜ Locked	Locked	Jun 09 2026
CANACCORD GENUITY	Locked ➜ Locked	Locked	Jun 08 2026

Analyst Rating	Date
Locked CANACCORD GENUITY: Locked ➜ Locked	Aug 12 2026
Locked CANACCORD GENUITY: Locked ➜ Locked	Jun 09 2026
Locked CANACCORD GENUITY: Locked ➜ Locked	Jun 08 2026

Discover more stocks with a high price target

NIO ADR 85.25%

Alibaba Group Holding Ltd 78.14%

Rheinmetall 72.55%

Tencent Holdings Ltd. 57.61%

Adyen 57.36%

Infineon 55.35%

Uber Technologies 51.77%

BYD 46.92%

Siemens Energy 46.72%

TUI 45.17%

Adidas 43.01%

Netflix 42.06%

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now